NPR
- Product code
- NPR
- Device name
- Test, Factor Ii G20210a Mutations, Genomic Dna Pcr
- Device class
- Class 2
- 21 CFR
- 21 CFR 864.7280
- Medical specialty
- Hematology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 1 (direct download)
- 510(k) clearances (all years, FDA)
- 5 (all years; only the last 3 years are listed here)
FDA classification definition
In vitro diagnostic test to detect the Factor II G20210A mutation in genomic DNA, as an aid to diagnosis in the evaluation of patients with suspected thrombophilia.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K250218 | 2025-02-21 | Cepheid | Xpert® FII & FV |
Official FDA classification page: NPR
Classification and pathway per current FDA publications. Data from openFDA (CC0).